IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution
Open Access
- 12 March 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 135 (11), 834-844
- https://doi.org/10.1182/blood.2019002279
Abstract
Follicular lymphoma B cells undergo continuous somatic hypermutation (SHM) of their immunoglobulin variable region genes, generating a heterogeneous tumor population. SHM introduces DNA sequences encoding N-glycosylation sites asparagine-X-serine/threonine (N-gly sites) within the V-region that are rarely found in normal B-cell counterparts. Unique attached oligomannoses activate B-cell receptor signaling pathways after engagement with calcium-dependent lectins expressed by tissue macrophages. This novel interaction appears critical for tumor growth and survival. To elucidate the significance of N-gly site presence and loss during ongoing SHM, we tracked site behavior during tumor evolution and progression in a diverse group of patients through next-generation sequencing. A hierarchy of subclones was visualized through lineage trees based on SHM semblance between subclones and their discordance from the germline sequence. We observed conservation of N-gly sites in more than 96% of subclone populations within and across diagnostic, progression, and transformation events. Rare N-gly-negative subclones were lost or negligible from successive events, in contrast to N-gly-positive subclones, which could additionally migrate between anatomical sites. Ongoing SHM of the N-gly sites resulted in subclones with different amino acid compositions across disease events, yet the vast majority of resulting DNA sequences still encoded for an N-gly site. The selection and expansion of only N-gly-positive subclones is evidence of the tumor cells’ dependence on sites, despite the changing genomic complexity as the disease progresses. N-gly sites were gained in the earliest identified lymphoma cells, indicating they are an early and stable event of pathogenesis. Targeting the inferred mannose-lectin interaction holds therapeutic promise.Keywords
This publication has 26 references indexed in Scilit:
- Genetics of Follicular Lymphoma TransformationCell Reports, 2014
- Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphomaNature Genetics, 2013
- Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphomaBlood, 2013
- Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectinsProceedings of the National Academy of Sciences of the United States of America, 2010
- Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma cloneBlood, 2009
- IgTree©: Creating Immunoglobulin variable region gene lineage treesJournal of Immunological Methods, 2008
- Prevalence and frequency of circulating t(14;18)‐MBR translocation carrying cells in healthy individualsInternational Journal of Cancer, 2008
- Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphomaMolecular Immunology, 2007
- Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?Leukemia, 2006
- Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.Proceedings of the National Academy of Sciences, 1985